INVESTIGATIONAL SITE NUMBER 840010
| Site name: | Investigational Site Number 840010 | Active Prostate Cancer Clinical Trials: | |
| Contact: | For site information, send an email with site number to | That match your search: | No search performed |
| Phone: | Not Provided | ||
| Site email: | Not Provided |
1
Active Prostate Cancer Clinical Trials at Investigational Site Number 840010:
| TRIAL ID | TITLE | TRIAL PHASE |
|---|---|---|
| NCT01308567 | Randomized, Open Label, Multi-Center Study Comparing Cabazitaxel at 25 mg/m2 and at 20 mg/mē in Combination With Prednisone Every 3 Weeks to Docetaxel in Combination With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer Not Pretreated With Chemotherapy | Phase 3 |